- Home
- AEVA vs FBLG Comparison
AEVA vs FBLG Comparison
Compare AEVA & FBLG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AEVA
- FBLG
- Stock Information
- Founded
- AEVA 2019
- FBLG 2021
- Country
- AEVA United States
- FBLG United States
- Employees
- AEVA N/A
- FBLG N/A
- Industry
- AEVA Auto Parts:O.E.M.
- FBLG
- Sector
- AEVA Consumer Discretionary
- FBLG
- Exchange
- AEVA Nasdaq
- FBLG NYSE
- Market Cap
- AEVA 177.0M
- FBLG 163.3M
- IPO Year
- AEVA N/A
- FBLG 2024
- Fundamental
- Price
- AEVA $2.44
- FBLG $2.09
- Analyst Decision
- AEVA Buy
- FBLG Strong Buy
- Analyst Count
- AEVA 5
- FBLG 1
- Target Price
- AEVA $10.03
- FBLG $16.00
- AVG Volume (30 Days)
- AEVA 260.9K
- FBLG 293.8K
- Earning Date
- AEVA 08-07-2024
- FBLG 11-02-2024
- Dividend Yield
- AEVA N/A
- FBLG N/A
- EPS Growth
- AEVA N/A
- FBLG N/A
- EPS
- AEVA N/A
- FBLG N/A
- Revenue
- AEVA $6,540,000.00
- FBLG N/A
- Revenue This Year
- AEVA $109.97
- FBLG N/A
- Revenue Next Year
- AEVA $136.96
- FBLG N/A
- P/E Ratio
- AEVA N/A
- FBLG N/A
- Revenue Growth
- AEVA 89.40
- FBLG N/A
- 52 Week Low
- AEVA $2.20
- FBLG $1.08
- 52 Week High
- AEVA $7.25
- FBLG $46.00
- Technical
- Relative Strength Index (RSI)
- AEVA 35.73
- FBLG N/A
- Support Level
- AEVA $2.79
- FBLG N/A
- Resistance Level
- AEVA $3.11
- FBLG N/A
- Average True Range (ATR)
- AEVA 0.24
- FBLG 0.00
- MACD
- AEVA -0.06
- FBLG 0.00
- Stochastic Oscillator
- AEVA 8.08
- FBLG 0.00
About AEVA Aeva Technologies Inc.
Aeva Technologies Inc through its Frequency Modulated Continuous Wave (FMCW) sensing technology, designs a 4D LiDAR-on-chip that, along with its proprietary software applications, has the potential to enable the adoption of LiDAR across broad applications from automated driving to consumer electronics, consumer health, industrial automation, and security application. The company operates in North America, EMEA, and Asia. The company derives the majority of its revenue from North America.
About FBLG FIBROBIOLOGICS INC
FibroBiologics Inc is a clinical-stage cell therapy company focused on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with significant unmet medical needs, including degenerative disc disease, multiple sclerosis, wound healing, and certain cancers, and potential extension of life applications including thymic and splenic involution reversal.